INDIANAPOLIS, Oct. 31, 2011 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug Administration (FDA) granted Premarket Approval (PMA) for its IgM antibody to ...
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug Administration (FDA) granted Premarket Approval (PMA) for its IgM antibody to hepatitis B core antigen (Anti-HBc IgM) ...
Roche Diagnostics (SIX: RO, ROG; OTCQX: RHHBY) announced today that it has introduced a complete battery of STAT immunoassays for cardiac biomarker testing on the cobas® 6000 analyzer series, an ...
The test helps diagnose infectious causes of vaginitis through the detection of bacteria associated with bacterial vaginosis and yeast associated with candida vaginitis.
The US Food & Drug Administration (:FDA) recently cleared Roche Holdings Ltd.’s (RHHBY) IgG Antibody to herpes simplex virus (:HSV) types 1 and 2 assays for use on cobas modular platforms. The ...
For the first time, certain immunosuppressive drug (ISD) assays can now be performed automatically on cobas® modular platforms, allowing laboratories to consolidate testing for a wide range of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results